Subsequently, many studies have shown that Smad4 is underexpressed in various human tumors, including stomach cancer, squamous cell carcinoma of the esophagus, and breast cancer, and Smad4 has been proposed as a prognostic marker for tumor formation and progression[18,31,32]. Here, SMAD4 is linked to breast cancer.